The top two are for scolds.
Point is Avita now have a product they can market and as the public become aware that ReCell is gold standard FDA approved care enrollment should be a lot faster.
Venous leg ulcers is a mega care market.
Well done Bread,
MB
- Forums
- ASX - By Stock
- AVH
- Ongoing clinical trials
Ongoing clinical trials, page-2
-
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.55 |
Change
0.020(0.79%) |
Mkt cap ! $172.2M |
Open | High | Low | Value | Volume |
$2.50 | $2.55 | $2.45 | $840.8K | 335.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 9686 | $2.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.55 | 10832 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3390 | 2.530 |
3 | 5980 | 2.510 |
2 | 2223 | 2.500 |
3 | 9399 | 2.490 |
2 | 8000 | 2.480 |
Price($) | Vol. | No. |
---|---|---|
2.550 | 10295 | 4 |
2.560 | 35646 | 6 |
2.590 | 4816 | 1 |
2.600 | 6000 | 2 |
2.610 | 4335 | 2 |
Last trade - 10.27am 06/08/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |